CN Bio PhysioMimix Organ-on-a-Chip data supports Inipharm’s INI-822 for metabolic liver disease treatment now in clinical testing Post author: Post published:December 4, 2023 Post category:uncategorized CN Bio today announced its PhysioMimix® assay for Non-alcoholic steatohepatitis (NASH). You Might Also Like Common viruses sharply raise heart attack and stroke risk, major global review shows October 30, 2025 Maternal happiness during pregnancy linked to child’s brain development January 30, 2024 New computer simulation offers insights into brain function October 10, 2024
Common viruses sharply raise heart attack and stroke risk, major global review shows October 30, 2025